Standard curves created for all primers had a slope of -3.3 ± 0.3 (data not shown). For quantification of amplicons, an individual gene was first amplified by PCR and cloned into the pGEM-Teasy vector (Promega, Madison, WI). Recombinant plasmid DNA was then purified and diluted serially 10-fold to generate a standard curve. Transcript copies corresponding to each gene of interest were calculated Pevonedistat in vivo using the Absolute Quantification Analysis program (Applied Biosystems) and normalized against copies of flaB. Table 1 Oligonucleotide primers

used in this study Gene Forward (5′-3′) Reverse (5′-3′) Cloning     flaB GGGAACTTGATTAGCCTGCGCAAT TCGAGCTTCTGATGATGCTGCT rpoS CTTGCAGGACAAATACAAAGAGGC TGGGACTATTGTCCAGGTTATATCTTT ospC CTGCTGATGAGTCTGTTAAAGGGC TTTGGACTTTCTGCCACAACAGGG ospA GCGTTTCAGTAGATTTGCCTGGTG

CCCTCTAATTTGGTGCCATTTGAGTCG dbpA CTTATATCATGTGGACTAACAGGAGC AGCACTCCTTGAGCTGTAGTTGGA qRT-PCR     flaB TGATTAGCCTGCGCAATCATT AATGACAGATGAGGTTGTAGCAGC rpoS CTGGACAAAGAAATAGAGGGATCTG CAAGGGTAATTTCAGGGTTAAAAGAA ospC GTACTAAAACTAAAGGTGCTGAAGAA GCATCTCTTTAGCTGCTTTTGACA ospA GGCGTAAAAGCTGACAAAAGTAAAGT TGTTTTGCCATCTTCTTTGAAAAC dbpA ACGAAGCGCTAAAGACATTACAGA GGCATCAAAATTTACGCCCTTA Acknowledgements We thank Jianli Zhou for Cell Cycle inhibitor technical assistance. This work was supported by NIH-NIAID Grants P-gp inhibitor AI-059062 (to MVN), AI-076705 (to SN) and AI-080615 (to UP), an Arthritis Foundation fellowship (to GN), and an award from the American Heart Association (to ZO). References 1. Bacon RM, Kugeler KJ, Mead Isotretinoin PS: Surveillance for Lyme disease-United States, 1992–2006. MMWR Surveill Summ 2008,57(10):1–9.PubMed 2. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP: Lyme disease-a tick-borne spirochetosis? Science 1982,216(4552):1317–1319.PubMedCrossRef 3. Steere AC, Grodzicki RL, Kornblatt AN, Craft JE, Barbour AG, Burgdorfer W, Schmid GP, Johnson E, Malawista SE: The spirochetal etiology of Lyme disease. N Engl J Med 1983,308(13):733–740.PubMedCrossRef 4. de Silva AM, Telford SR, Brunet LR, Barthold SW, Fikrig E: Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

J Exp Med 1996,183(1):271–275.PubMedCrossRef 5. Hodzic E, Feng S, Freet KJ, Borjesson DL, Barthold SW: Borrelia burgdorferi population kinetics and selected gene expression at the host-vector interface. Infect Immun 2002,70(7):3382–3388.PubMedCrossRef 6. Montgomery RR, Malawista SE, Feen KJ, Bockenstedt LK: Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J Exp Med 1996,183(1):261–269.PubMedCrossRef 7. Ohnishi J, Piesman J, de Silva AM: Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci USA 2001,98(2):670–675.PubMedCrossRef 8.